← Back to Search

Positive Psychosocial Intervention for Dementia (IPPI Trial)

N/A
Waitlist Available
Led By Katherine Abbott, PhD
Research Sponsored by Miami University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a positive psychosocial interaction can help reduce distress/depression in nursing home residents living with dementia. Care partners will interact 2x/week for 6 months and track impact.

Who is the study for?
This trial is for long-term nursing home residents with dementia and signs of distress or depression. Participants must have a low mental status score (0-12 on BIMS) and show certain behaviors like aggression, rejection of care, or restlessness. It's not for those planning to leave the nursing home within six months.
What is being tested?
The study tests if it's possible to regularly provide Individualized Positive Psychosocial Interaction (IPPI) to these residents over six months, and if this can be tracked using electronic medical records. Care partners will conduct two tailored IPPI sessions weekly.
What are the potential side effects?
Since IPPI involves social interaction tailored to individual preferences rather than medication, there are no typical drug side effects; however, participants may experience varying emotional responses based on their personal comfort with the interactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Behavioral or Psychological Symptoms of Dementia or Depressive Symptoms
Secondary study objectives
Staff-Reported

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: experimentalExperimental Treatment1 Intervention
The experimental arm involves a brief positive interaction around a preferred activity or personal care routine.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,184,412 Total Patients Enrolled
292 Trials studying Dementia
23,634,378 Patients Enrolled for Dementia
Penn State UniversityOTHER
368 Previous Clinical Trials
127,462 Total Patients Enrolled
14 Trials studying Dementia
4,016 Patients Enrolled for Dementia
Miami UniversityLead Sponsor
14 Previous Clinical Trials
2,785 Total Patients Enrolled

Media Library

experimental Clinical Trial Eligibility Overview. Trial Name: NCT05980299 — N/A
Dementia Clinical Trial 2023: experimental Highlights & Side Effects. Trial Name: NCT05980299 — N/A
~56 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top